List of insiders holdings for Aquestive Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner | 2022-02-11 16:03:40 | 10,117,434 0 | 10,117,434 | Form 13G |
| Schobel Alexander Mark Chief Innovation/Tech Officer | 2024-10-02 14:16:27 | 980,726 0 | 980,726 | Form 4/A |
| Barber Daniel President and CEO | 2024-10-02 14:15:25 | 826,478 0 | 826,478 | Form 4/A |
| Kendall Keith J CEO and President | 2022-03-14 11:24:23 | 375,000 0 | 375,000 | Form 4 |
| BRAENDER LORI J SVP, General Counsel | 2024-03-12 13:47:17 | 313,231 0 | 313,231 | Form 4 |
| Wargacki Stephen Chief Science Officer | 2024-10-02 14:15:47 | 261,414 0 | 261,414 | Form 4/A |
| Kraus Carl N Chief Medical Officer | 2024-08-12 14:45:02 | 251,681 0 | 251,681 | Form 4 |
| TOTH A ERNEST JR SVP, Chief Financial Officer | 2024-03-12 13:47:06 | 248,295 0 | 248,295 | Form 4 |
| Boyd Peter E. See Remark | 2024-03-12 13:47:29 | 237,628 0 | 237,628 | Form 4 |
| Jung Cassie SVP, Operations | 2024-10-02 14:14:55 | 233,066 2,044 | 235,110 | Form 4/A |
| Maxwell John T. SVP-Chief Financial Officer | 2020-08-19 08:55:53 | 150,614 0 | 150,614 | Form 4 |
| Cochran John Director | 2024-06-21 13:50:27 | 137,486 0 | 137,486 | Form 4 |
| BROWN GREGORY B Director | 2024-06-21 13:51:01 | 113,085 0 | 113,085 | Form 4 |
| Truitt Kenneth Chief Medical Officer | 2022-09-08 16:30:27 | 100,000 0 | 100,000 | Form 4 |
| Marshall Ken W. SVP, Chief Commercial Officer | 2023-08-09 16:30:32 | 75,000 0 | 75,000 | Form 4 |
| Wood Theresa SVP-HR and Org. Development | 2022-03-14 11:26:29 | 70,000 0 | 70,000 | Form 4 |
| Jenkins Abigail L. Director | 2024-05-13 13:40:07 | 57,000 0 | 57,000 | Form 4 |
| COSTA SANTO J Director | 2024-06-21 13:50:10 | 55,327 0 | 55,327 | Form 4 |
| Scibetta James S Director | 2021-06-17 18:51:00 | 51,635 0 | 51,635 | Form 4 |
| Korczynski Sherry SVP Sales and Marketing | 2024-06-12 17:14:25 | 50,000 0 | 50,000 | Form 3/A |
| Slatko Gary H SVP, Chief Medical Officer | 2020-03-18 16:48:39 | 50,000 0 | 50,000 | Form 4 |
| Krop Julie Director | 2024-06-21 13:50:44 | 38,000 0 | 38,000 | Form 4 |
| Taglietti Marco Director | 2024-06-21 13:51:17 | 38,000 0 | 38,000 | Form 4 |
| MORRIS TIMOTHY E Director | 2024-06-21 13:51:29 | 38,000 0 | 38,000 | Form 4 |
| Lurker Nancy Director | 2021-06-17 18:51:09 | 20,000 0 | 20,000 | Form 4 |